Literature DB >> 22368275

Activation of the pyrin inflammasome by intracellular Burkholderia cenocepacia.

Mikhail A Gavrilin1, Dalia H A Abdelaziz, Mahmoud Mostafa, Basant A Abdulrahman, Jaykumar Grandhi, Anwari Akhter, Arwa Abu Khweek, Daniel F Aubert, Miguel A Valvano, Mark D Wewers, Amal O Amer.   

Abstract

Burkholderia cenocepacia is an opportunistic pathogen that causes chronic infection and induces progressive respiratory inflammation in cystic fibrosis patients. Recognition of bacteria by mononuclear cells generally results in the activation of caspase-1 and processing of IL-1β, a major proinflammatory cytokine. In this study, we report that human pyrin is required to detect intracellular B. cenocepacia leading to IL-1β processing and release. This inflammatory response involves the host adapter molecule ASC and the bacterial type VI secretion system (T6SS). Human monocytes and THP-1 cells stably expressing either small interfering RNA against pyrin or YFP-pyrin and ASC (YFP-ASC) were infected with B. cenocepacia and analyzed for inflammasome activation. B. cenocepacia efficiently activates the inflammasome and IL-1β release in monocytes and THP-1. Suppression of pyrin levels in monocytes and THP-1 cells reduced caspase-1 activation and IL-1β release in response to B. cenocepacia challenge. In contrast, overexpression of pyrin or ASC induced a robust IL-1β response to B. cenocepacia, which correlated with enhanced host cell death. Inflammasome activation was significantly reduced in cells infected with T6SS-defective mutants of B. cenocepacia, suggesting that the inflammatory reaction is likely induced by an as yet uncharacterized effector(s) of the T6SS. Together, we show for the first time, to our knowledge, that in human mononuclear cells infected with B. cenocepacia, pyrin associates with caspase-1 and ASC forming an inflammasome that upregulates mononuclear cell IL-1β processing and release.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22368275      PMCID: PMC3482472          DOI: 10.4049/jimmunol.1102272

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis.

Authors:  M J Welsh; A E Smith
Journal:  Cell       Date:  1993-07-02       Impact factor: 41.582

2.  Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages.

Authors:  Luigi Franchi; Amal Amer; Mathilde Body-Malapel; Thirumala-Devi Kanneganti; Nesrin Ozören; Rajesh Jagirdar; Naohiro Inohara; Peter Vandenabeele; John Bertin; Anthony Coyle; Ethan P Grant; Gabriel Núñez
Journal:  Nat Immunol       Date:  2006-04-30       Impact factor: 25.606

3.  Akt-mediated proinflammatory response of mononuclear phagocytes infected with Burkholderia cenocepacia occurs by a novel GSK3β-dependent, IκB kinase-independent mechanism.

Authors:  Thomas J Cremer; Prexy Shah; Estelle Cormet-Boyaka; Miguel A Valvano; Jonathan P Butchar; Susheela Tridandapani
Journal:  J Immunol       Date:  2011-06-22       Impact factor: 5.422

4.  Lipopolysaccharide of Burkholderia cepacia and its unique character to stimulate murine macrophages with relative lack of interleukin-1beta-inducing ability.

Authors:  H Shimomura; M Matsuura; S Saito; Y Hirai; Y Isshiki; K Kawahara
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles.

Authors:  Julie Lamothe; Kassidy K Huynh; Sergio Grinstein; Miguel A Valvano
Journal:  Cell Microbiol       Date:  2006-07-26       Impact factor: 3.715

6.  The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses.

Authors:  Vijay A K Rathinam; Zhaozhao Jiang; Stephen N Waggoner; Shruti Sharma; Leah E Cole; Lisa Waggoner; Sivapriya Kailasan Vanaja; Brian G Monks; Sandhya Ganesan; Eicke Latz; Veit Hornung; Stefanie N Vogel; Eva Szomolanyi-Tsuda; Katherine A Fitzgerald
Journal:  Nat Immunol       Date:  2010-03-28       Impact factor: 25.606

7.  Pyrin critical to macrophage IL-1beta response to Francisella challenge.

Authors:  Mikhail A Gavrilin; Srabani Mitra; Sudarshan Seshadri; Jyotsna Nateri; Freweine Berhe; Mark W Hall; Mark D Wewers
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

8.  Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants.

Authors:  Je-Wook Yu; Teresa Fernandes-Alnemri; Pinaki Datta; Jianghong Wu; Christine Juliana; Leobaldo Solorzano; Margaret McCormick; ZhiJia Zhang; Emad S Alnemri
Journal:  Mol Cell       Date:  2007-10-26       Impact factor: 17.970

9.  Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

Authors:  Samiya Razvi; Lynne Quittell; Ase Sewall; Hebe Quinton; Bruce Marshall; Lisa Saiman
Journal:  Chest       Date:  2009-06-08       Impact factor: 9.410

10.  Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia.

Authors:  Karen E Keith; Daniel W Hynes; Judith E Sholdice; Miguel A Valvano
Journal:  Microbiology       Date:  2009-04       Impact factor: 2.777

View more
  59 in total

1.  The Inflammasome Adaptor ASC Induces Procaspase-8 Death Effector Domain Filaments.

Authors:  Parimala R Vajjhala; Alvin Lu; Darren L Brown; Siew Wai Pang; Vitaliya Sagulenko; David P Sester; Simon O Cridland; Justine M Hill; Kate Schroder; Jennifer L Stow; Hao Wu; Katryn J Stacey
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

Review 2.  The myths we believed in familial Mediterranean fever: what have we learned in the past years?

Authors:  Seza Ozen; Ezgi Deniz Batu
Journal:  Semin Immunopathol       Date:  2015-04-02       Impact factor: 9.623

Review 3.  Converging roles of caspases in inflammasome activation, cell death and innate immunity.

Authors:  Si Ming Man; Thirumala-Devi Kanneganti
Journal:  Nat Rev Immunol       Date:  2015-12-14       Impact factor: 53.106

Review 4.  Mechanisms governing inflammasome activation, assembly and pyroptosis induction.

Authors:  Sannula Kesavardhana; Thirumala-Devi Kanneganti
Journal:  Int Immunol       Date:  2017-05-01       Impact factor: 4.823

5.  Identification of multifaceted binding modes for pyrin and ASC pyrin domains gives insights into pyrin inflammasome assembly.

Authors:  Parimala R Vajjhala; Sebastian Kaiser; Sarah J Smith; Qi-Rui Ong; Stephanie L Soh; Katryn J Stacey; Justine M Hill
Journal:  J Biol Chem       Date:  2014-07-08       Impact factor: 5.157

6.  Helicobacter pylori controls NLRP3 expression by regulating hsa-miR-223-3p and IL-10 in cultured and primary human immune cells.

Authors:  Suneesh Kumar Pachathundikandi; Steffen Backert
Journal:  Innate Immun       Date:  2017-11-16       Impact factor: 2.680

7.  Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis.

Authors:  Deepika Sharma; Ankit Malik; Clifford S Guy; Rajendra Karki; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  Gastroenterology       Date:  2017-12-02       Impact factor: 22.682

8.  TNF/TNFR axis promotes pyrin inflammasome activation and distinctly modulates pyrin inflammasomopathy.

Authors:  Deepika Sharma; Ankit Malik; Clifford Guy; Peter Vogel; Thirumala-Devi Kanneganti
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

9.  Tyrosine phosphatase inhibition induces an ASC-dependent pyroptosis.

Authors:  Mohammed G Ghonime; Obada R Shamaa; Ramadan A Eldomany; Mikhail A Gavrilin; Mark D Wewers
Journal:  Biochem Biophys Res Commun       Date:  2012-07-27       Impact factor: 3.575

10.  The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.

Authors:  Lawton K Chung; Yong Hwan Park; Yueting Zheng; Igor E Brodsky; Patrick Hearing; Daniel L Kastner; Jae Jin Chae; James B Bliska
Journal:  Cell Host Microbe       Date:  2016-08-25       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.